Legal & General Group Plc boosted its position in Analogic Co. (NASDAQ:ALOG) by 6.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,362 shares of the medical research company’s stock after buying an additional 1,613 shares during the period. Legal & General Group Plc owned approximately 0.20% of Analogic worth $2,125,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. Ameriprise Financial Inc. increased its holdings in Analogic by 10.6% during the 3rd quarter. Ameriprise Financial Inc. now owns 354,655 shares of the medical research company’s stock worth $29,703,000 after purchasing an additional 34,021 shares in the last quarter. Comerica Bank increased its holdings in Analogic by 7.5% during the 3rd quarter. Comerica Bank now owns 153,274 shares of the medical research company’s stock worth $12,147,000 after purchasing an additional 10,747 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its holdings in Analogic by 38.5% during the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 6,300 shares of the medical research company’s stock worth $528,000 after purchasing an additional 1,750 shares in the last quarter. BNP Paribas Arbitrage SA increased its holdings in Analogic by 50.9% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 6,667 shares of the medical research company’s stock worth $558,000 after purchasing an additional 2,248 shares in the last quarter. Finally, Hodges Capital Management Inc. increased its holdings in Analogic by 33.3% during the 3rd quarter. Hodges Capital Management Inc. now owns 20,000 shares of the medical research company’s stock worth $1,675,000 after purchasing an additional 5,000 shares in the last quarter. 97.68% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have commented on ALOG shares. Zacks Investment Research raised Analogic from a “hold” rating to a “buy” rating and set a $93.00 price objective for the company in a report on Tuesday, October 10th. Jefferies Group reissued a “hold” rating and set a $80.00 price objective on shares of Analogic in a report on Friday, December 8th. Finally, BidaskClub lowered Analogic from a “hold” rating to a “sell” rating in a report on Thursday, December 7th.
Analogic (NASDAQ:ALOG) last announced its earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.32. Analogic had a positive return on equity of 5.09% and a negative net margin of 15.06%. The firm had revenue of $106.90 million for the quarter, compared to the consensus estimate of $100.55 million. During the same quarter in the previous year, the business earned $0.43 EPS. The company’s revenue was down 11.7% compared to the same quarter last year. analysts forecast that Analogic Co. will post 2.86 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were paid a $0.10 dividend. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.47%. Analogic’s payout ratio is presently -7.01%.
WARNING: “Analogic Co. (NASDAQ:ALOG) Shares Bought by Legal & General Group Plc” was originally reported by Week Herald and is the property of of Week Herald. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://weekherald.com/2018/01/13/legal-general-group-plc-has-2-13-million-stake-in-analogic-co-alog.html.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.